Nagler A - Search Results

1

Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT.

Battipaglia G, Boumendil A, Labopin M, Ciceri F, Tischer J, Stelljes M, Ehninger G, Beelen D, Finke J, Van Lint MT, Eder M, Afanasyev B, Fanin R, Mohty M, Ruggeri A, Nagler A. Battipaglia G, et al. Among authors: nagler a. Bone Marrow Transplant. 2019 Sep;54(9):1499-1510. doi: 10.1038/s41409-019-0459-7. Epub 2019 Feb 4. Bone Marrow Transplant. 2019. PMID: 30718798 Clinical Trial.

2

Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice.

Shimoni A, Nagler A. Shimoni A, et al. Among authors: nagler a. Cancer Treat Res. 2002;110:113-36. doi: 10.1007/978-1-4615-0919-6_6. Cancer Treat Res. 2002. PMID: 11908195 Review.

3

Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplantation.

Slavin S, Nagler A, Shapira MY, Aker M, Gabriel C, Or R. Slavin S, et al. Among authors: nagler a. J Clin Immunol. 2002 Mar;22(2):64-9. doi: 10.1023/a:1014423617596. J Clin Immunol. 2002. PMID: 11998894 Review.

4

Successful major surgical recovery of a patient following haploidentical stem cell transplantation for chronic myeloid leukemia in blast crisis and aspergillosis.

Varadi G, Svirsky O, Nagler A. Varadi G, et al. Among authors: nagler a. Acta Haematol. 2002;108(1):29-32. doi: 10.1159/000063056. Acta Haematol. 2002. PMID: 12145464

5

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase.

Or R, Shapira MY, Resnick I, Amar A, Ackerstein A, Samuel S, Aker M, Naparstek E, Nagler A, Slavin S. Or R, et al. Among authors: nagler a. Blood. 2003 Jan 15;101(2):441-5. doi: 10.1182/blood-2002-02-0535. Epub 2002 Sep 19. Blood. 2003. PMID: 12393604 Free article.

6

Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity.

Shimoni A, Bielorai B, Toren A, Hardan I, Avigdor A, Yeshurun M, Ben-Bassat I, Nagler A. Shimoni A, et al. Among authors: nagler a. Exp Hematol. 2003 May;31(5):428-34. doi: 10.1016/s0301-472x(03)00047-x. Exp Hematol. 2003. PMID: 12763142 Free article.

7

Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma.

Shimoni A, Hardan I, Avigdor A, Yeshurun M, Raanani P, Ben-Bassat I, Nagler A. Shimoni A, et al. Among authors: nagler a. Br J Haematol. 2003 Aug;122(3):457-64. doi: 10.1046/j.1365-2141.2003.04446.x. Br J Haematol. 2003. PMID: 12877674 Free article.

8

Hematopoietic stem-cell transplantation using umbilical-cord blood.

Cohena Y, Nagler A. Cohena Y, et al. Among authors: nagler a. Leuk Lymphoma. 2003 Aug;44(8):1287-99. doi: 10.1080/1042819031000077016. Leuk Lymphoma. 2003. PMID: 12952221 Review.

9

Cord blood biology and transplantation.

Cohen Y, Nagler A. Cohen Y, et al. Among authors: nagler a. Isr Med Assoc J. 2004 Jan;6(1):39-46. Isr Med Assoc J. 2004. PMID: 14740509 Free article. Review.

10

Umbilical cord blood transplantation--how, when and for whom?

Cohen Y, Nagler A. Cohen Y, et al. Among authors: nagler a. Blood Rev. 2004 Sep;18(3):167-79. doi: 10.1016/S0268-960X(03)00064-X. Blood Rev. 2004. PMID: 15183901 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,427 results

Search Page